Docetaxel Market Owns A Huge Opportunity

Docetaxel is a new anticancer drug belonging to the taxane compounds

. Abroad approves it for the treatment of advanced breast cancer and non-small cell lung cancer. Docetaxel has a good effect on advanced ovarian cancer patients with application failures of cisplatin and carboplatin. In addition, docetaxel has significant effects on prostate cancer, pancreatic cancer, soft tissue tumors, head and neck cancer, stomach cancer, esophageal cancer and other solid tumors.

Docetaxel has markets in more than 80 countries such as the United States, Japan. It has been launched in 1996. At that time, China began the clinical validation after the successful sale. As the price of the product is relatively expensive, can not meet the clinical demand, and since 2002 there have been a number of Chinese companies began to produce imitations of docetaxel. In recent years, more and more in-depth research with the international academic community on dcetaxel, the product has become one of the commonly used drugs of the Chinese journal of clinical oncology, the market contains a giant business opportunities, is the generic objectives of the R & D institutions.

Market experience has shown that the price reduction strategy in the short term, but not wise. Through the analysis of paclitaxel market will find that the brand is the most important, the price is the first element, because paclitaxel lowest price, its sales have not been into the top three of China's manufacturing enterprises.

In addition, the second level of the anticancer drug market, the agents marketing companies will be more active part of the market share by virtue of the strong network of regional chia seed agents in the local area. Docetaxel into the hospital market, product quality and marketing strategy will be the focus of the third round of the contest. Market structure become clear after three contests, a place of business fall into two categories: one is a professional marketing organization focusing on long-term, highly specialized marketing model to lay a solid foundation for irinotecan market expansion. The other is the marketing model of the enterprise application agents, to seize market share within a period of time through rapid low-cost expansion.

In recent years, with commence of China's macro-regulation and market competition, pharmaceutical market starts to re-layout towards the direction of gradual and orderly development. In this context, companies need to establish their own brands. The anticancer drug market needs to gradually build outstanding marketing team with specialized promotion skills and build a broad platform for the professional marketing of oncology products. Practice has proved that specialized marketing is the direction of market development for an oncology product.

by: anelwew

POST COMMENT

Are You Struggling As A Blogger? 5 Tips To Help If You Are! Membrane Switch For High Tech Devices Reasons To Falsify Jetking Fraud Which To Choose Among The 4 Types Of Hdtv The Best Laptop Packs Ways To Find Best Teens Military Schools Programs Tune Up: Is A Car Tune Up Still Necessary? Florists Supply Flowers For Every Occasion Mobile Construction Waste Crushing Station Finest Rug Cleaning Outfit In Melbourne The Facial Oxygen Machine - Everything You Need To Know What You Need To Know About Moisture Removal Choosing The Right Headlights For Your Car